Participated in a demonstration experiment of a video diagnostic test that enables early diagnosis of infectious diseases including the new corona by photographing the throat with a smartphone by Remixpoint, Juntendo University and Scalar Marketing.
Category: Goods and services
Release issuer: Remixpoint Co., Ltd.
-Aiming for early commercialization- Remixpoint Co., Ltd. (Securities code: 3825, Headquarters: 3-2-1 Roppongi, Minato-ku, Tokyo, President and CEO Genki Oda) (hereinafter referred to as "the Company") Is Professor Takeshi Tanigawa, Graduate School of Medicine, Juntendo University, and SCARA Marketing Co., Ltd. (2-6-1 Motofujisawa, Fujisawa City, Kanagawa Prefecture, President Kiyokazu Yamamoto) (hereinafter, "SCARA M") Infection using the "scalar imaging method" that enables early diagnosis of upper airway infections including the new coronavirus infection using images of the oral cavity and pharynx taken with a smartphone, etc. We are pleased to inform you that we have decided to participate as a partner in a demonstration experiment (hereinafter referred to as "this demonstration experiment") for the practical application of early diagnosis and examination of diseases. On December 2, 2020, Juntendo University and SCARA Co., Ltd. (6-2-3 Nishi-Shinjuku, Shinjuku-ku, Tokyo, President Masao Yamamoto) were infected with upper respiratory tract infections such as colds and influenza, especially new coronavirus infections. We issued a press release stating that we have developed an inspection device for the purpose of early diagnosis of infection by images of the oral cavity and pharynx in the case of illness. Toward its practical application, SCARA M and Juntendo University have been planning this demonstration experiment. By participating in this demonstration experiment as a partner, we aim for the early commercialization and popularization of early diagnostic and testing methods for infectious diseases. Background to our participation in this demonstration experiment We started the infectious disease control business in 2019, and in response to the spread of the new coronavirus infection, we will start the infectious disease control business in 2020. We are developing our business in earnest by setting it as one of the pillars of. "Airborne infection control," "droplet infection control," "contact infection control," such as sales of UV irradiation equipment and products that utilize the time-required chlorite ion aqueous solution "MA-T" to realize comprehensive infectious disease control. ] And infection control enlightenment solutions. While the spread of the new coronavirus infection has not subsided, I strongly felt the importance of realizing early response by early diagnosis and early detection of infectious diseases in addition to infection control measures. We have decided to participate in this demonstration experiment by the company as a partner. In addition, based on the results of this demonstration experiment, we have a business including the spread of "SCARA Imaging Method" that realizes highly accurate, low-cost, and immediate infectious disease diagnostic tests with SCARA M. We are planning to proceed with development and marketing. What is the "scalar imaging method"? In conventional tests centered on PCR tests, the judgment accuracy is particularly low in the early stages of infection, and false positives (actually, new coronavirus) due to sample collection and sample storage conditions, etc. It can be positive (it will be positive even though it is not an infection) and false negative (it will be negative even though it is actually a new coronavirus infection). On the other hand, research results have been reported that the initial stage of infection is the most susceptible period for new coronavirus infections, and the problem is that asymptomatic people spread the infection, so patients in the early stages of infection It is said that identification and early response are important. Viruses and bacteria that cause upper respiratory tract infections often invade through the nose and throat, so it is effective to determine the presence or absence of infection based on the inflammation of the throat in the early stages of infection. Especially in the case of new coronavirus infection, there are many people who are infected but do not develop the disease or have no subjective symptoms, so it is said that it is meaningful to be able to perform daily tests to prevent the spread of the infection. The "scalar imaging method" is a test method that has the potential to solve the problems of conventional test methods, and is an epoch-making test method that improves test accuracy, shortens the judgment time, and enables positive judgment from the initial stage of infection. It will be an inspection method. Features of "SCARA Imaging Method" In addition, inspection equipment can be provided in various forms, from a method in which an individual checks the infection status on a smartphone on a daily basis, to a stand type used at large-scale events, etc. We are considering providing it. Based on the results of this demonstration experiment, we will promote the practical application and popularization of inspection by the "scalar imaging method". Specifically, we plan to rent inspection equipment to companies, event venues, public facilities, etc. to diagnose and detect infectious diseases at an early stage and to build a foundation for early response to infectious diseases. Doing. Future plans The "SCARA Imaging Method" is an inspection method that sets it apart from conventional infectious disease inspections, but it is still in the development and demonstration stages at this stage. In the future, we would like to ask all of you for your cooperation in the following items in order to make the "SCARA Imaging Method" a more accurate inspection technology and to put it into practical use at an early stage. 1. Cooperation in clinical research We will improve our testing technology by securing the number of cases. Companies, medical institutions, research institutes, and local governments who can cooperate in clinical research are free to use the diagnostic imaging test using the "SCARA Imaging Method" (conditions apply to the location and number of examinations). Please contact us as there are). 2. Cooperation in the introduction of trials In addition to clinical research, please cooperate in the introduction of trials. For companies who can cooperate in the introduction of the test, we will offer a diagnostic imaging test using the "scalar imaging method" at a special price (please contact us for conditions). 3. Introducing implementation at large-scale events In the future, early identification and early response to infectious diseases will be important in order to carry out daily life and economic activities with peace of mind. In particular, the practical application of diagnostic imaging tests using the "scalar imaging method" at large-scale events will lead to the realization of early identification and early response to infectious diseases in daily life. We would like to ask the event management company and the large-scale customer attraction facility management company to cooperate in the test implementation of the diagnostic imaging test using the "scalar imaging method". For inquiries regarding this matter, please contact the following
* Product prices, specifications, service details, etc. described in the news release are as of the date of announcement. Please note that it is subject to change without notice.